Identification of candidate driver genes in common focal chromosomal aberrations of microsatellite stable colorectal cancer

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Burghel, George J ^a   Lin, Wei Yu ^a   Whitehouse, Helen ^a   Brock, Ian ^a   Hammond, David ^a   Bury, Jonathan ^a   Stephenson, Yvonne ^a   George, Rina ^a   Cox, Angela ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MITOGEN ACTIVATED PROTEIN KINASE; POTASSIUM CHANNEL; PROTEIN P53;

APOPTOSIS; ARTICLE; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER MODEL; CONTEXT CORRECTED COMMON ABERRATION; COPY NUMBER VARIATION; FEMALE; FOCAL MINIMAL COMMON REGION; GENE DELETION; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENOME; HUMAN; HUMAN TISSUE; IFNAR1 GENE; IFNAR2 GENE; INTERMETHOD COMPARISON; KCNMA1 GENE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; NFKBIA GENE; ONCOGENE; PRDM16 GENE; RASSF3 GENE; RPA3 GENE; SIGNAL TRANSDUCTION; TNS1 GENE; TUMOR SUPPRESSOR GENE;

COLORECTAL NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; GENES, NEOPLASM; GENOMICS; HUMANS; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECURRENCE;

EID: 84893175273     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083859     Document Type: Article

References (47)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90. PubMed: 21296855.
2. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global Cancer Statistics, 2002. CA: a Cancer Journal for Clinicians 55: 74-108. (Pubitemid 40372904)
3. Migliore L, Migheli F, Spisni R, Coppede F (2011) Genetics, cytogenetics, and epigenetics of colorectal cancer. Journal of biomedicine & biotechnology 2011: 792362.
4. Derks S, Postma C, Carvalho B, Bosch SMvd, Moerkerk PTM et al. (2008) Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations. Carcinogenesis 29: 434-439. (Pubitemid 351359685)
5. Issa J-P (2008) Colon Cancer: It's CIN or CIMP. Cancer Research 14: 5939-5940.
6. Pino MS, Chung DC (2010) The chromosomal instability pathway in colon cancer. Gastroenterology 138: 2059-2072. doi:10.1053/j.gastro.2009.12.065. PubMed: 20420946.
7. Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C (2003) The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 3: 695-701. doi:10.1038/nrc1165. PubMed: 12951588. (Pubitemid 37328824)
8. Cheng Y-W, Pincas H, Bacolod MD, Schemmann G, Giardina SF et al. (2008) CpG Island Methylator Phenotype Associates with Low-Degree Chromosomal Abnormalities in Colorectal. Cancer - Cancer Research 14: 6005-6013.
9. Ogino S, Goel A (2008) Molecular Classification and Correlates in Colorectal Cancer. J Mol Diagn 10: 13-27. doi:10.2353/jmoldx.2008.070082. PubMed: 18165277. (Pubitemid 351184831)
10. Kozma L, Kiss I, Szakáll S, Ember I (1994) Investigation of c-myc oncogene amplification in colorectal cancer. Cancer Lett 81: 165-169. doi:10.1016/0304-3835(94)90198-8. PubMed: 8012933. (Pubitemid 24184651)
11. Ozakyol A, Ozdemir M, Artan S (2006) Fish detected p53 deletion and N-MYC amplification in colorectal cancer. Hepatogastroenterology 53: 192-195. PubMed: 16608022.
12. Tanaka T, Watanabe T, Kazama Y, Tanaka J, Kanazawa T et al. (2006) Chromosome 18q deletion and Smad4 protein inactivation correlate with liver metastasis: A study matched for T- and N-classification. Br J Cancer 95: 1562-1567. doi:10.1038/sj.bjc.6603460. PubMed: 17088901. (Pubitemid 44863360)
13. Martin ES, Tonon G, Sinha R, Xiao Y, Feng B et al. (2007) Common and distinct genomic events in sporadic colorectal cancer and diverse cancer types. Cancer Res 67: 10736-10743. doi:10.1158/0008-5472.CAN-07-2742. PubMed: 18006816. (Pubitemid 350145900)
14. Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J et al. (2006) Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 66: 2129-2137. doi:10.1158/0008-5472.CAN-05-2569. PubMed: 16489013.
15. Sheffer M, Bacolod MD, Zuk O, Giardina SF, Pincas H et al. (2009) Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer. Proc Natl Acad Sci U S A 106: 7131-7136. doi:10.1073/pnas.0902232106. PubMed: 19359472.
16. Brosens RP, Haan JC, Carvalho B, Rustenburg F, Grabsch H et al. (2010) Candidate driver genes in focal chromosomal aberrations of stage II colon cancer. J Pathol 221: 411-424. PubMed: 20593488.
17. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463: 899-905. doi:10.1038/nature08822. PubMed: 20164920.
18. Hermsen M, Postma C, Baak J, Weiss M, Rapallo A et al. (2002) Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 123: 1109-1119. doi:10.1053/gast.2002.36051. PubMed: 12360473.
19. Diep CB, Kleivi K, Ribeiro FR, Teixeira MR, Lindgjaerde OC et al. (2006) The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes Chromosomes Cancer 45: 31-41. doi:10.1002/gcc.20261. PubMed: 16145679. (Pubitemid 46930859)
20. Lassmann S, Weis R, Makowiec F, Roth J, Danciu M et al. (2007) Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. J Mol Med (Berl) 85: 293-304. doi:10.1007/s00109-006-0126-5. PubMed: 17143621.
21. Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S et al. (2009) Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 58: 79-89. doi:10.1136/gut. 2007.143065. PubMed: 18829976.
22. Andersen CL, Lamy P, Thorsen K, Kjeldsen E, Wikman F et al. (2011) Frequent genomic loss at chr16p13.2 is associated with poor prognosis in colorectal cancer. Int J Cancer, 129: 1848-58. PubMed: 21154748.
23. Bredel M, Scholtens DM, Yadav AK, Alvarez AA, Renfrow JJ et al. (2011) NFKBIA Deletion in Glioblastomas. N Engl J Med, 364: 627-37. PubMed: 21175304.
24. Poulogiannis G, Ichimura K, Hamoudi RA, Luo F, Leung SY et al. (2010) Prognostic relevance of DNA copy number changes in colorectal cancer. J Pathol 220: 338-347. doi:10.1002/path.2640. PubMed: 19911421.
25. Poulogiannis G, McIntyre RE, Dimitriadi M, Apps JR, Wilson CH et al. (2010) PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc Natl Acad Sci U S A 107: 15145-15150. doi:10.1073/pnas.1009941107. PubMed: 20696900.
26. Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E et al. (2010) Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet 42: 77-82. doi:10.1038/ng.491. PubMed: 19946270.
27. Dyrsø T, Li J, Wang K, Lindebjerg J, Kølvraa S et al. (2011) Identification of chromosome aberrations in sporadic microsatellite stable and unstable colorectal cancers using array comparative genomic hybridization. Cancer Genetics 204: 84-95. doi:10.1016/j.cancergencyto.2010.08. 019. PubMed: 21504706.
28. Murphy KM, Zhang S, Geiger T, Hafez MJ, Bacher J et al. (2006) Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn 8: 305-311. doi:10.2353/jmoldx.2006.050092. PubMed: 16825502. (Pubitemid 44063806)
29. Bonfield JK, Rada C, Staden R (1998) Automated detection of point mutations using fluorescent sequence trace subtraction. Nucleic Acids Res 26: 3404-3409. doi:10.1093/nar/26.14.3404. PubMed: 9649626. (Pubitemid 28322750)
30. Béroud C, Soussi T (1996) APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 24: 121-124. doi:10.1093/nar/24.1.121. PubMed: 8594558. (Pubitemid 26085747)
31. Brink M, de Goeij AF, Weijenberg MP, Roemen GM, Lentjes MH et al. (2003) K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis 24: 703-710. doi:10.1093/carcin/bgg009. PubMed: 12727799. (Pubitemid 36592405)
32. Velho S, Oliveira C, Ferreira A, Ferreira AC, Suriano G et al. (2005) The prevalence of PIK3CA mutations in gastric and colon cancer. Eur J Cancer 41: 1649-1654. doi:10.1016/j.ejca.2005.04.022. PubMed: 15994075. (Pubitemid 40981849)
33. Oliveira C, Velho S, Moutinho C, Ferreira A, Preto A et al. (2007) KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene 26: 158-163. doi:10.1038/sj.onc.1209758. PubMed: 16953233. (Pubitemid 46067341)
34. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113. doi:10.1126/science.1145720. PubMed: 17932254. (Pubitemid 350134889)
35. Leary RJ, Lin JC, Cummins J, Boca S, Wood LD et al. (2008) Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers. Proc Natl Acad Sci U S A 105: 16224-16229. doi:10.1073/pnas.0808041105. PubMed: 18852474.
36. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57. PubMed: 19131956.
37. Raychaudhuri S, Plenge RM, Rossin EJ, Ng AC, Purcell SM et al. (2009) Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet 5: e1000534. PubMed: 19557189.
38. Zhivotovsky B, Kroemer G (2004) Apoptosis and genomic instability. Nat Rev Mol Cell Biol 5: 752-762. doi:10.1038/nrg1449. PubMed: 15340382. (Pubitemid 39208184)
39. Jacquemart IC, Springs AE, Chen WY (2009) Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice. Int J Oncol 34: 517-528.
40. Zhang KX, Matsui Y, Hadaschik BA, Lee C, Jia W et al. (2010) Downregulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death. Int J Cancer 127: 830-838. PubMed: 19957332.
41. Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT (1999) Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. Oncogene 18: 3063-3070. doi:10.1038/sj.onc.1202893. PubMed: 10340377. (Pubitemid 29261226)
42. Man TK, Lu XY, Jaeweon K, Perlaky L, Harris CP et al. (2004) Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma. BMC Cancer 4: 45. doi:10.1186/1471-2407-4-45. PubMed: 15298715.
43. Shing DC, Trubia M, Marchesi F, Radaelli E, Belloni E et al. (2007) Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice. J Clin Invest 117: 3696-3707. PubMed: 18037989. (Pubitemid 350224081)
44. Chen H, Duncan IC, Bozorgchami H, Lo SH (2002) Tensin1 and a previously undocumented family member, tensin2, positively regulate cell migration. Proc Natl Acad Sci U S A 99: 733-738. doi:10.1073/pnas.022518699. PubMed: 11792844. (Pubitemid 34106579)
45. Kabbarah O, Nogueira C, Feng B, Nazarian RM, Bosenberg M et al. (2010) Integrative genome comparison of primary and metastatic melanomas. PLOS ONE 5: e10770. doi:10.1371/journal.pone.0010770. PubMed: 20520718.
46. Bloch M, Ousingsawat J, Simon R, Schraml P, Gasser TC et al. (2007) KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene 26: 2525-2534. doi:10.1038/sj.onc.1210036. PubMed: 17146446. (Pubitemid 46597266)
47. Khaitan D, Sankpal UT, Weksler B, Meister EA, Romero IA et al. (2009) Role of KCNMA1 gene in breast cancer invasion and metastasis to brain. BMC Cancer 9: 258. doi:10.1186/1471-2407-9-258. PubMed: 19640305.